BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1109 related articles for article (PubMed ID: 29253680)

  • 1. Effect of lacosamide on depression and anxiety symptoms in patients with focal refractory epilepsy: A prospective multicenter study.
    Rocamora R; Ley M; Molins A; Toledo M; Sansa G; Bertol V; Becerra JL; Carreño M; Mauri JÁ
    Epilepsy Behav; 2018 Feb; 79():87-92. PubMed ID: 29253680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of lacosamide on cognition, quality-of-life measures, and quality of life in patients with refractory partial epilepsy.
    Lancman ME; Fertig EJ; Trobliger RW; Perrine K; Myers L; Iyengar SS; Malik M
    Epilepsy Behav; 2016 Aug; 61():27-33. PubMed ID: 27315132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.
    Maschio M; Zarabla A; Maialetti A; Fabi A; Vidiri A; Villani V; Giannarelli D
    Epilepsy Behav; 2017 Aug; 73():83-89. PubMed ID: 28623754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LAM study: Effects of lacosamide on behaviour and quality of life in patients with epilepsy.
    Alfaro A; Asensio M; García-Escrivá A; Medrano V; Salom JM; Tortosa D; Palao S; Lezcano M; Berenguer L; Navarro M; Cerdán M; Buendía JF; Giner JC
    Neurologia (Engl Ed); 2019; 34(1):1-6. PubMed ID: 27993420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and tolerability of adjuvant lacosamide: The role of clinical characteristics and mechanisms of action of concomitant AEDs.
    Neal A; D'Souza W; Hepworth G; Lawn N; Cook M; Nikpour A
    Epilepsy Behav; 2018 Mar; 80():25-32. PubMed ID: 29396359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved irritability, mood, and quality of life following introduction of perampanel as late adjunctive treatment for epilepsy.
    Moraes JS; Hepworth G; Ignatiadis S; Dharan A; Carne R; Seneviratne U; Cook MJ; D'Souza WJ
    Epilepsy Behav; 2020 Mar; 104(Pt A):106883. PubMed ID: 32045874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy in patients with primary brain tumors: The impact on mood, cognition, and HRQOL.
    Rahman Z; Wong CH; Dexter M; Olsson G; Wong M; Gebsky V; Nahar N; Wood A; Byth K; King M; Bleasel AB
    Epilepsy Behav; 2015 Jul; 48():88-95. PubMed ID: 26136184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of perampanel treatment on quality of life and psychiatric symptoms in patients with drug-resistant focal epilepsy: An observational study in Italy.
    Deleo F; Quintas R; Turner K; Didato G; Zambrelli E; Pappalardo I; Chiesa V; Pastori C; de Curtis M; Canevini MP; Villani F
    Epilepsy Behav; 2019 Oct; 99():106391. PubMed ID: 31371205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, multicenter, noninterventional study in Taiwan to evaluate the safety and tolerability of lacosamide as adjunctive therapy for epilepsy in clinical practice.
    Wu T; Chuang YC; Huang HC; Lim SN; Hsieh PF; Lee WT; Cheng MY; Tsai MH; Jou SB; Chang CW; Hsieh HY; Du X; Hellot S; McClung C; Hung C
    Epilepsy Behav; 2020 Dec; 113():107464. PubMed ID: 33152580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LACONORTE study: Efficacy and security of lacosamide as first add-on therapy for focal-onset epilepsy in real-life setting.
    Muñoz-Lopetegi A; López-González FJ; Rodríguez-Osorio X; Pato Pato A; Bellas Lamas P; Abella-Corral J; Castro Vilanova MD; Garea MJ; Gil López JA; Ruiz-Martínez J; Poza JJ
    Epilepsy Res; 2018 Sep; 145():51-54. PubMed ID: 29890341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenges of assessing effectiveness of lacosamide using electronic medical record databases.
    Kalilani L; Halpern R; Seare J; Dedeken P
    Epilepsy Behav; 2018 Aug; 85():195-199. PubMed ID: 30032807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term efficacy of add-on lacosamide treatment in children and adolescents with refractory epilepsies: A single-center observational study.
    Rosati A; Ilvento L; Rizzi R; Doccini V; Leo MC; Pugi A; De Masi S; Guerrini R
    Epilepsia; 2018 May; 59(5):1004-1010. PubMed ID: 29663335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of lacosamide on depression and anxiety in patients with epilepsy.
    Moseley BD; Cole D; Iwuora O; Strawn JR; Privitera M
    Epilepsy Res; 2015 Feb; 110():115-8. PubMed ID: 25616463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of quality of life in patients with refractory focal epilepsy who were not eligible for surgery or who rejected surgery.
    Elsharkawy AE; Thorbecke R; Ebner A; May TW
    Epilepsy Behav; 2012 Jun; 24(2):249-55. PubMed ID: 22534356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of lamotrigine on mood in older adults with epilepsy and co-morbid depressive symptoms: an open-label, multicentre, prospective study.
    Fakhoury TA; Miller JM; Hammer AE; Vuong A
    Drugs Aging; 2008; 25(11):955-62. PubMed ID: 18947263
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidisciplinary management improves anxiety, depression, medication adherence, and quality of life among patients with epilepsy in eastern China: A prospective study.
    Zheng Y; Ding X; Guo Y; Chen Q; Wang W; Zheng Y; Wang S; Ding Y; Ding M
    Epilepsy Behav; 2019 Nov; 100(Pt A):106400. PubMed ID: 31634729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of health-related quality of life in pharmacoresistant epilepsy: results from a large multicenter study of consecutively enrolled patients using validated quantitative assessments.
    Luoni C; Bisulli F; Canevini MP; De Sarro G; Fattore C; Galimberti CA; Gatti G; La Neve A; Muscas G; Specchio LM; Striano S; Perucca E;
    Epilepsia; 2011 Dec; 52(12):2181-91. PubMed ID: 22136077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES).
    Rudà R; Houillier C; Maschio M; Reijneveld JC; Hellot S; De Backer M; Chan J; Joeres L; Leunikava I; Glas M; Grant R
    Epilepsia; 2020 Apr; 61(4):647-656. PubMed ID: 32329527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study.
    Del Bianco C; Placidi F; Liguori C; Mari L; Ulivi M; Ornello R; Pisani A; Mercuri NB; Izzi F
    Epilepsy Behav; 2019 May; 94():178-182. PubMed ID: 30959275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adjunctive lacosamide on mood and quality of life in patients with epilepsy.
    Nakhutina L; Kunnakkat SD; Coleman M; Lushbough C; Arnedo V; Soni N; Grant AC
    Epilepsy Behav; 2017 Aug; 73():90-94. PubMed ID: 28623755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.